STOCK TITAN

Wellington discloses 4.97% Haleon (NYSE: HLN) ownership

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Wellington Management Group LLP and related entities report their ownership of Haleon plc common stock on an amended Schedule 13G. As of 12/31/2025, they beneficially own 443,046,686 shares, representing 4.97% of the class, with shared voting and dispositive power through investment adviser clients.

The securities are held in the ordinary course of business by Wellington-managed clients and are not held for the purpose of changing or influencing control of Haleon. No individual client is reported to hold more than five percent of the class.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Wellington Management Group LLP
Signature:Taisia Lowe
Name/Title:Regulatory Analyst
Date:02/10/2026
Wellington Group Holdings LLP
Signature:Taisia Lowe
Name/Title:Regulatory Analyst
Date:02/10/2026
Wellington Investment Advisors Holdings LLP
Signature:Taisia Lowe
Name/Title:Regulatory Analyst
Date:02/10/2026

FAQ

What stake in Haleon plc (HLN) does Wellington report in this Schedule 13G/A?

Wellington reports beneficial ownership of 443,046,686 Haleon plc common shares, representing 4.97% of the class as of December 31, 2025. The holdings are reported with shared voting and dispositive power through Wellington-managed investment adviser clients.

Which Wellington entities are listed as reporting persons for Haleon (HLN)?

The filing lists Wellington Management Group LLP, Wellington Group Holdings LLP, and Wellington Investment Advisors Holdings LLP as reporting persons. These entities sit above various Wellington investment advisers whose clients own Haleon shares of record, with Wellington exercising shared voting and dispositive power.

How are voting and dispositive powers over Haleon (HLN) shares allocated in this filing?

The reporting entities show zero sole voting and dispositive power, but shared voting power over 351,705,316 shares and shared dispositive power over 443,046,686 shares. These powers arise through Wellington’s role over client accounts managed by its affiliated investment advisers holding Haleon stock.

Does any single Wellington client hold over 5% of Haleon (HLN) shares?

No. The filing states that while clients of Wellington investment advisers own the reported Haleon securities, no such client is known to have the right to receive dividends or sale proceeds with respect to more than five percent of this class of securities.

What does the Schedule 13G/A say about Wellington’s intent regarding control of Haleon (HLN)?

The certification states the Haleon securities were acquired and are held in the ordinary course of business, not for the purpose or effect of changing or influencing control of Haleon, and not in connection with any control-related transaction, aside from activities tied to a nomination under Rule 240.14a-11.

Who ultimately controls the Wellington advisers holding Haleon (HLN) shares?

The filing explains that Wellington Investment Advisors Holdings LLP controls the Wellington investment advisers directly or through Wellington Management Global Holdings, Ltd. Wellington Investment Advisors Holdings LLP is owned by Wellington Group Holdings LLP, which in turn is owned by Wellington Management Group LLP.
Haleon

NYSE:HLN

HLN Rankings

HLN Latest News

HLN Latest SEC Filings

HLN Stock Data

48.45B
4.45B
0.02%
12.85%
0.36%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United Kingdom
Weybridge